Earlier Natural Menopause Risk Increased for Women in Socially Vulnerable Neighborhoods
By Elana Gotkine HealthDay Reporter
THURSDAY, May 29, 2025 -- Women residing in U.S. neighborhoods with high social vulnerability have a higher risk for earlier natural menopause, according to a study published online May 22 in JAMA Network Open.
Zhi Lin, from Harvard Medical School in Boston, and colleagues examined the association of the Social Vulnerability Index (SVI) with age of natural menopause onset and menopausal symptom severity in a cohort study using data from a prospective cohort of women. Participant inclusion required geocoded residential addresses at enrollment (1999 to 2002), eight-year follow-up (2006 to 2010), and 13-year follow-up (2012 to 2016).
Of the 691 women included in the study, 12.6, 6.0, and 6.2 percent resided in neighborhoods with a very high SVI at enrollment, at eight-year follow-up, and at 13-year follow-up, respectively. The median age of natural menopause was earlier for women residing in neighborhoods with very high versus very low SVI at enrollment (52.0 versus 53.0 years), eight-year follow-up (51.0 versus 53.0 years), and 13-year follow-up (51.0 versus 53.0 years). The risk for earlier natural menopause was higher in association with residence in neighborhoods with a very high versus very low SVI at enrollment, eight-year follow-up, and 13-year follow-up. There was no association for SVI with menopausal symptoms.
"The study highlighted the need to address disparate contexts within neighborhoods to achieve more equitable reproductive health outcomes in women," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-30 06:00
Read more

- Three New Color Food Additives From Natural Sources Approved by FDA
- Low Alcohol Use Disorder Treatment Rates Seen in Cancer Survivors
- North Dakota Becomes the Latest State to Report Measles Outbreak
- GLISTEN Phase III Trial Results Show Linerixibat Significantly Improves Cholestatic Pruritus in Primary Biliary Cholangitis
- RFK Jr. Ends COVID Vaccine Urging for Healthy Kids, Pregnant Women
- Marijuana Use While Pregnant Linked to Preterm Birth, Low Birth Weight
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions